Erol Demir

1.1k total citations
59 papers, 344 citations indexed

About

Erol Demir is a scholar working on Transplantation, Nephrology and Infectious Diseases. According to data from OpenAlex, Erol Demir has authored 59 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Transplantation, 16 papers in Nephrology and 13 papers in Infectious Diseases. Recurrent topics in Erol Demir's work include Renal Transplantation Outcomes and Treatments (17 papers), Renal Diseases and Glomerulopathies (15 papers) and COVID-19 Clinical Research Studies (9 papers). Erol Demir is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Renal Diseases and Glomerulopathies (15 papers) and COVID-19 Clinical Research Studies (9 papers). Erol Demir collaborates with scholars based in Türkiye, United States and United Kingdom. Erol Demir's co-authors include Aydın Türkmen, Halil Yazıcı, Ahmet Burak Dirim, Seda Şafak, Fatma Savran Oğuz, Yasemin Özlük, Mehmet Şükrü Sever, Yaşar Çalışkan, Özgür Akın Oto and İşın Kiliçaslan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and Environmental Science and Pollution Research.

In The Last Decade

Erol Demir

52 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erol Demir Türkiye 12 131 96 86 63 61 59 344
Ahmet Burak Dirim Türkiye 10 82 0.6× 76 0.8× 41 0.5× 39 0.6× 31 0.5× 45 212
Charlotte Laurent France 10 136 1.0× 40 0.4× 90 1.0× 49 0.8× 60 1.0× 27 327
Agathe Pardon France 9 96 0.7× 113 1.2× 68 0.8× 35 0.6× 19 0.3× 15 313
George Goshua United States 8 101 0.8× 46 0.5× 11 0.1× 94 1.5× 55 0.9× 55 354
Grażyna Moszkowska Poland 10 81 0.6× 29 0.3× 103 1.2× 177 2.8× 66 1.1× 38 385
Elisa Delbarba Italy 7 223 1.7× 185 1.9× 14 0.2× 19 0.3× 46 0.8× 13 435
Fatemeh Pour-Reza-Gholi Iran 13 86 0.7× 39 0.4× 190 2.2× 39 0.6× 120 2.0× 28 445
Marcia M. L. Kho Netherlands 15 66 0.5× 47 0.5× 293 3.4× 187 3.0× 140 2.3× 44 566
Sridhar R. Allam United States 8 42 0.3× 19 0.2× 122 1.4× 121 1.9× 76 1.2× 18 277
Michelle Elias France 5 121 0.9× 58 0.6× 21 0.2× 8 0.1× 29 0.5× 8 220

Countries citing papers authored by Erol Demir

Since Specialization
Citations

This map shows the geographic impact of Erol Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol Demir more than expected).

Fields of papers citing papers by Erol Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erol Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol Demir. The network helps show where Erol Demir may publish in the future.

Co-authorship network of co-authors of Erol Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Erol Demir. A scholar is included among the top collaborators of Erol Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erol Demir. Erol Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hilbrands, Luuk B., Gabriel C. Oniscu, Ilaria Gandolfini, et al.. (2024). Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group. Clinical Kidney Journal. 18(1). sfae367–sfae367.
2.
Demir, Erol, et al.. (2024). Halk Oyuncuların Beslenme Bilgi Düzeylerinin İncelenmesi. SHILAP Revista de lepidopterología. 11(S1). 14–23.
3.
Demir, Erol, et al.. (2024). Outcome and Risk Factors for Mortality in Peritoneal Dialysis Patients: 22 Years of Experience in a Turkish Center. SHILAP Revista de lepidopterología. 33(2). 223–228.
4.
Pérez‐Sáez, María José, Núria Montero, Dolores Redondo‐Pachón, et al.. (2023). Immunosuppression of HLA identical living-donor kidney transplant recipients: A systematic review. Transplantation Reviews. 37(4). 100787–100787. 1 indexed citations
5.
Özlük, Yasemin, Ahmet Burak Dirim, Erol Demir, et al.. (2023). Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?. SHILAP Revista de lepidopterología. 32(3). 209–215.
6.
Çalışkan, Yaşar, Erol Demir, Egemen Cebeci, et al.. (2022). COSMC expression as a predictor of remission in IgA nephropathy. International Urology and Nephrology. 55(4). 1033–1044. 2 indexed citations
7.
Demir, Erol, Hamad Dheir, Ramazan Danış, et al.. (2022). COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the First Two Waves of Pandemic. BMC Nephrology. 23(1). 183–183. 15 indexed citations
8.
Dirim, Ahmet Burak, Erol Demir, Özgür Akın Oto, Halil Yazıcı, & Aydın Türkmen. (2021). Page Kidney: A Rare Cause of Resistant Hypertension Early After Renal Transplantation. Balkan Medical Journal. 38(5). 316–317.
9.
Oto, Özgür Akın, Erol Demir, Ahmet Burak Dirim, et al.. (2021). Clinical significance of glomerular C3 deposition in primary membranous nephropathy. Journal of Nephrology. 34(2). 581–587. 13 indexed citations
10.
Demir, Erol, Murathan Uyar, Berna Yelken, et al.. (2020). COVID‐19 in kidney transplant recipients: A multicenter experience in Istanbul. Transplant Infectious Disease. 22(5). e13371–e13371. 38 indexed citations
11.
Dirim, Ahmet Burak, Erol Demir, Seda Şafak, et al.. (2020). Fatal SARS-CoV-2 infection in a renal transplant recipient. CEN Case Reports. 9(4). 409–412. 10 indexed citations
12.
Demir, Erol, Yaşar Çalışkan, Yasemin Özlük, et al.. (2020). P0353EFFECT OF RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY MEMBRANOUS NEPHROPATHY. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
13.
Dirim, Ahmet Burak, Erol Demir, Seda Şafak, et al.. (2020). Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19. Kidney International Reports. 5(10). 1811–1814. 3 indexed citations
14.
Demir, Erol, Ahmet Burak Dirim, Halil Yazıcı, et al.. (2019). Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients. Transplantation Proceedings. 51(4). 1118–1120. 2 indexed citations
15.
Demir, Erol, et al.. (2019). Different Courses of Hepatitis B Reinfection After Renal Transplant: A Case Report. PubMed. 17(3). 408–410. 1 indexed citations
16.
Demir, Erol, et al.. (2019). Tuberculosis Mastitis: Fever of Unknown Origin in a Kidney Transplant Recipient. SHILAP Revista de lepidopterología. 15(4). 272–274. 1 indexed citations
17.
Tefik, Tzevat, et al.. (2017). EFFECT OF URIDINE DIPHOSPHATE-GLUCURONOSYLTRANSFERASE POLYMORPHISMS ON THE PLASMA CONCENTRATIONS OF MYCOPHENOLIC ACID IN TURKISH RENAL TRANSPLANT PATIENTS. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 80(3). 104–110. 3 indexed citations
18.
Şahutoğlu, Tuncay, Halil Yazıcı, Erol Demir, et al.. (2017). Tac-MMF Versus CsA-MMF/CsA-AZA–Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation. Transplantation Proceedings. 49(3). 454–459. 2 indexed citations
19.
Karadeniz, Meltem Savran, Tzevat Tefik, Halil Yazıcı, et al.. (2017). Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism. Transplantation Proceedings. 49(3). 490–496. 5 indexed citations
20.
Yazıcı, Halil, et al.. (2017). A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy. Transplantation Proceedings. 49(3). 541–545. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmet Burak Dirim Breakdown of academic impact, for papers by Charlotte Laurent Breakdown of academic impact, for papers by Agathe Pardon Breakdown of academic impact, for papers by George Goshua Breakdown of academic impact, for papers by Grażyna Moszkowska Breakdown of academic impact, for papers by Elisa Delbarba Breakdown of academic impact, for papers by Fatemeh Pour-Reza-Gholi Breakdown of academic impact, for papers by Marcia M. L. Kho Breakdown of academic impact, for papers by Sridhar R. Allam Breakdown of academic impact, for papers by Michelle Elias
Rankless by CCL
2026